Selincro

Selincro is a medicine used in the treatment of alcoholism, together with psychological support to promote adherence to treatment and reduction of alcohol consumption. The active ingredient in this medicine is nalmefene.

Selincro is a drug produced by the Lundbeck laboratory, found in the form of a tablet.

Selincro indications

Selincro is indicated for reducing alcohol consumption in adult patients with alcohol dependence, without physical withdrawal symptoms and who do not need immediate detoxification.

How to use Selincro

The Selincro method of use consists of taking a maximum dose of 1 tablet per day.

Before starting treatment, the patient's clinical status, alcohol dependence and alcohol consumption level should be evaluated by the doctor. Selincro can be taken with or without food.

Side Effects of Selincro

Side effects of Selincro may be decreased appetite, insomnia, disturbance, confusional state, restlessness, decreased libido, loss of libido) hallucination, hallucination, tactile, hallucination, dissociation, dizziness, headache, drowsiness, tremor, disturbances, paraesthesia, hyposthesia, tachycardia, palpitations, nausea, vomiting, dry mouth, hyperhidrosis, muscle spasms, fatigue, asthenia. general malaise, unpleasant feeling or decreased weight.

Contraindications for Selincro

Selincro is contraindicated in patients over 65 years of age, people with kidney and liver problems, or who are hypersensitive to any component of Selincro.

Selincro is not recommended during pregnancy. The safety and efficacy of Selincro in children and adolescents over 18 years of age have not been established.

Selincro is also contracted by patients who use opioid analgesics, with current or recent opioid dependence, with acute opioid withdrawal symptoms, with suspected recent use of opioids.